FindTrial
Sign In

Sera application in leprosy patients

Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansenâ??s disease- a tear proteomic study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/07/003802
Enrollment
102
Registered
2013-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dry eye patients of Hansens disease

Interventions

Control Intervention1: Cord blood seum,autologous serum,artificial tear drop: Dry eye patients of Hansens disease were randomized into three groups(ALS,CBS and preservative free AT group)to get design

Sponsors

Regional Institute of ophthalmology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: both sexes of patients of Hansen disease of age group 23yr to 75 yr were enrolled

Exclusion criteria

Exclusion criteria: Patients(both sexes) having active ocular and lid infection, active keartitis , lid deformity, history of punctual occlusion within last three months, pregnancy and lactation, were excluded from the study.

Design outcomes

Primary

MeasureTime frame
To evaluate comparative efficacy of topically applied 20% umbilical cord blood serum (UBS) and 20% autologous serum (ALS) with preservative free artificial tear drop (AT) in moderate to severe dry patients of Hansenâ??s disease along with change in tear protein profile.Timepoint: 21/04/2011—

Secondary

MeasureTime frame
nilTimepoint: none—

Countries

India

Contacts

Public ContactDr Somnath Mukhopadhyay

Regional Institute of Ophthalmology,kolkata

himadri.datta@gmail.com9830127929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 7, 2026